MentionFox
Home › funding signals › 60 DEGREES PHARMACEUTICALS, INC.
Form D · on the record

60 DEGREES PHARMACEUTICALS — $1.08M Form D filing, February 2025

Before you sell to, join or invest in 60 DEGREES PHARMACEUTICALS, INC.

MentionFox check on 60 DEGREES PHARMACEUTICALS, INC.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/60-degrees-pharmaceuticals-inc-form-d-25000002

Check 60 DEGREES PHARMACEUTICALS, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about 60 DEGREES PHARMACEUTICALS, INC.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

60 DEGREES PHARMACEUTICALS, INC. filed a Form D with the Securities and Exchange Commission on 2025-02-12.

60 DEGREES PHARMACEUTICALS, INC. filed a Form D notice of an exempt securities offering with the SEC on February 12, 2025. The filing reports $1.08M sold. Its industry group is Pharmaceuticals. It names Geoffrey Dow (Chief Executive Officer and President) (SEC Form D, February 12, 2025).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Pharmaceuticals raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on 60 DEGREES PHARMACEUTICALS, INC. →

Sell to companies like 60 DEGREES PHARMACEUTICALS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

60 DEGREES PHARMACEUTICALS, INC.

New Form D on file · 2025-02-12 · the record

$1.08M
raise on the record
D
filing
4
investors in
DISTRICT OF COLUMBIA
based
Open the record →

What the record says

FilingForm D
Filed2025-02-12
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
Year formed2022
BasedWASHINGTON, DISTRICT OF COLUMBIA
CIK1946563
Accession0001946563-25-000002

Pitching, partnering or investing alongside them? See who really runs and owns 60 DEGREES PHARMACEUTICALS, INC.

Watch 60 DEGREES PHARMACEUTICALS, INC.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind 60 DEGREES PHARMACEUTICALS, INC., from the filings we hold.

Raised through the same sales agent

H.C.WAINWRIGHT & CO., LLC received sales compensation on this raise and on 29 other raises we hold, nearest in date first:

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with 60 DEGREES PHARMACEUTICALS, INC.?

Get the full cited report on 60 DEGREES PHARMACEUTICALS, INC.

What the filing shows about 60 DEGREES PHARMACEUTICALS, INC.

  • 4 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on 60 DEGREES PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives 60 DEGREES PHARMACEUTICALS, INC.'s address as 1025 Connecticut Avenue Nw, Suite 1000, Washington, DC 20036.

What the filing says

  • Offered: $1,075,003. Sold: $1,075,003. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 4 had already invested. (filing)
  • Date of first sale: February 5, 2025. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters (marked as an estimate). (filing)
  • On sales commissions and finders' fees: the filing adds “Includes a 1.0% cash fee on gross proceeds from the registered shares paid to HC Wainwright. No separate commission was charged for the warrants, but the fee may be attributed to the private placement of the warrants.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on 60 DEGREES PHARMACEUTICALS, INC. See pricing

Is 60 DEGREES PHARMACEUTICALS, INC. a real, registered company?

60 DEGREES PHARMACEUTICALS, INC. is a registered filer with the SEC (CIK 1946563) and has filed since 2023-05-24. 3 filings are on record, the latest on 2025-02-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs 60 DEGREES PHARMACEUTICALS, INC.?

60 DEGREES PHARMACEUTICALS, INC.'s Form D of 2025-02-12 names Geoffrey Dow as its officers, directors or promoters.

How much has 60 DEGREES PHARMACEUTICALS, INC. raised?

Its new offerings report $3.87M sold across 3 offerings, as its own filings state.

Filing history · 3 filings on this registrant
Form D · 2023-05-24 · $1.75MForm D · 2025-02-11 · $1.04MForm D · 2025-02-12 · $1.08M · this page 2023-05-24 2025-02-12

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week

Trailing twelve months. 154 filings in Pharmaceuticals, totalled by week.

Want the whole picture on 60 DEGREES PHARMACEUTICALS, INC.?

What the filing shows about 60 DEGREES PHARMACEUTICALS, INC.

  • 4 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on 60 DEGREES PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on 60 DEGREES PHARMACEUTICALS, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind 60 DEGREES PHARMACEUTICALS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for 60 DEGREES PHARMACEUTICALS, INC.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

60 DEGREES PHARMACEUTICALS, INC.: Raised $1.08M, Form D filed 2025-02-12
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/60-degrees-pharmaceuticals-inc-form-d-25000002
Last updated 2026-11-05
Primary record: SEC filing 1 · SEC filing 2
60 DEGREES PHARMACEUTICALS raised $1.08M — SEC Form D filing, February 2025. MentionFox, 2026-11-05. https://mentionfox.com/funding/60-degrees-pharmaceuticals-inc-form-d-25000002